Charles River Laboratories (CRL) Tops Q1 EPS by 8c; Boosts FY16 EPS Outlook
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $230.09 --0%
EPS Growth %: -25.9%
Financial Fact:
Continuing operations (in dollars per share): 0.79
Today's EPS Names:
ESCA, LICT, NKSH, More
EPS Growth %: -25.9%
Financial Fact:
Continuing operations (in dollars per share): 0.79
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $0.98, $0.08 better than the analyst estimate of $0.90. Revenue for the quarter came in at $354.9 million versus the consensus estimate of $354.91 million.
GUIDANCE:
Charles River Laboratories sees FY2016 EPS of $4.32-$4.45, versus the consensus of $4.34.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Equifax (EFX) shares tumble on weak Q1 revenue, guidance miss
- Apogee Enterprises (APOG) Tops Q4 EPS by 13c ; Offers Guidance
- First Industrial Realty (FR) Tops Q1 EPS by 21c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
